This paper collates frequently asked questions (FAQs) on the reporting of OTC derivatives contracts (OTCD) in Singapore. It is part of AIMA’s series of initiatives to assist managers with complying with their regulatory obligations under Singapore’s regulations on reporting of OTC derivatives contracts. Managers may access the other resources on AIMA’s website to supplement the information provided in these FAQs.
The FAQs were put together from questions and answers that have been kindly submitted and discussed by AIMA members that are part of the Singapore Working Group on OTCD reporting. The FAQs deal with matters that are not explicitly addressed by the regulations and are designed to provide practical guidance to members on suggested best operational practice. Where members have specific questions on the applicable law or regulations, members are encouraged to seek their own legal, regulatory or compliance advice.
AIMA intends to update the FAQs from time to time to provide further assistance to managers as the Singapore OTC reporting regime continues to develop. Members who wish to raise matters for consideration by the Singapore Working Group or for inclusion in future updates of the FAQs or to propose other initiatives may contact AIMA for assistance.
Sin Yee Koh
Director, Integrity Consulting
Partner, Singapore, Simmons & Simmons